Clinical Trial Update: Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating liposomal doxorubicin for advanced gastric cancer and esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• liposomal doxorubicin (doxorubicin liposomal)

Snippet

Sponsor: University of Leicester | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: UNKNOWN